FDA approves first oral tablet for alopecia treatment (WTOP)

June 15, 2022

The Food and Drug Administration approved Olumiant, a drug that restores hair growth and can act as a treatment for alopecia Monday.

Alopecia is an autoimmune disorder in which the immune system attacks hair follicles, resulting in hair loss on the scalp and, in some cases, the rest of the body.

This is the first systemic treatment for the disorder, which affects hundreds of thousands of people every year, said Dr. Adam Friedman, professor and chair of dermatology at The George Washington University School of Medicine and Health Sciences.

“This is extraordinary,” Friedman said. “Up until now, we’ve been using many different medications, all of which are not approved and being used off-label to manage this condition. But, we had nothing else.”

 

Read the full article on WTOP.com

Latest News

November 9, 2022
The GW Medical Faculty Associates is pleased to announce the appointment of Barry Browning to serve as the executive director for surgical services. In this role, Browning is responsible for recruiting and managing highly qualified managers across multiple locations and functions within the areas…
November 7, 2022
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is pleased to welcome LaQuandra S. Nesbitt, MD, MPH, immediate-past director of DC Health, to serve as the new executive director of the Center for Population Health Sciences and Health Equity. In this role, Nesbitt…
October 21, 2022
October is Breast Cancer Awareness Month, and though the incidence of breast cancer is high, early detection is the key to successful outcomes. According to the National Cancer Society, nearly 4 million women in the United States with a history of the disease are alive today, mainly because of…